Iain Peter Murray Buchanan
Direktor/Vorstandsmitglied bei Allecra Therapeutics GmbH
Aktive Positionen von Iain Peter Murray Buchanan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Direktor/Vorstandsmitglied | 01.01.2013 | - |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Direktor/Vorstandsmitglied | - | - |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Direktor/Vorstandsmitglied | - | - |
Celloryx AG | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Iain Peter Murray Buchanan
Ehemalige bekannte Positionen von Iain Peter Murray Buchanan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYNAIRGEN PLC | Direktor/Vorstandsmitglied | 29.06.2010 | 01.12.2022 |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | 16.11.2009 | 17.08.2010 |
Vorstandsvorsitzender | 17.08.2010 | 16.06.2015 | |
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Vorstandsvorsitzender | 01.01.2004 | 01.01.2010 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.01.1994 | - |
Cilag AG
Cilag AG Miscellaneous Commercial ServicesCommercial Services Cilag AG conducts pharmaceutical research and development activities. It is an international operating company integrated in the pharmaceuticals group of Johnson & Johnson that provides its customers with APIs, health care and pharmaceutical products worldwide. The company was founded in 1936 by Dr. Bernhard Joos and is headquartered in Schaffhausen, Switzerland. | Corporate Officer/Principal | 01.01.1987 | - |
░░░░░░ ░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Iain Peter Murray Buchanan
University of St. Andrews | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 5 |
Schweiz | 5 |
Deutschland | 3 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 8 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
SYNAIRGEN PLC | Health Technology |
Private Unternehmen | 10 |
---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Cilag AG
Cilag AG Miscellaneous Commercial ServicesCommercial Services Cilag AG conducts pharmaceutical research and development activities. It is an international operating company integrated in the pharmaceuticals group of Johnson & Johnson that provides its customers with APIs, health care and pharmaceutical products worldwide. The company was founded in 1936 by Dr. Bernhard Joos and is headquartered in Schaffhausen, Switzerland. | Commercial Services |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | Distribution Services |
Biogen SA | |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Health Technology |
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Health Technology |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Commercial Services |
Celloryx AG |